Immunogenicity and protective potential of a bacterially expressed recombinant dihydrolipoamide succinyltransferase (rE2o) of Brucella abortus in BALB/c mice

  • Shailendra Kumar Verma
  • Shikha Jain
  • Subodh Kumar
Original Paper


Brucellosis is one of the world’s major zoonoses. No vaccine is available for the prevention of brucellosis in human. Efforts are needed to develop an effective, safe, stable, vaccine with long lasting immunity against human brucellosis. Here, we cloned and expressed recombinant dihydrolipoamide succinyltransferase (rE2o) of Brucella abortus in Escherichia coli and purified up to homogeneity by metal affinity chromatography. The purified rE2o is immunoreactive with brucellosis positive cattle sera. The immunogenicity and the protective potential of recombinant dihydrolipoamide succinyltransferase (rE2o) were evaluated in BALB/c mice with two different adjuvants i.e., Freund’s and aluminium hydroxide gel. Mice were tested for humoral immune response by ELISA. Cell mediated immune response was tested by lymphocyte proliferation assay and cytokine profiling. The recombinant E2o (rE2o) generated high IgG antibody and its isotypes IgG1, and induced significant production of INF-γ, IL-10 and IL-4 cytokines. The rE2o protein induced significant lymphoproliferation of splenocytes. Altogether, these results suggest that rE2o induces a mixed but a predominant Th2 type of immune response in BALB/c mice and provides partial protection against challenge with pathogenic Brucella abortus.


Brucella abortus Aluminium hydroxide gel Dihydrolipoamide succinyltransferase Antibody isotypes Cytokine profiling 



The authors are thankful to Dr. R. Vijayaraghavan, Director, DRDE, for providing all facilities and support required for this study. The authors are also thankful to Dr. B. Bhardwaj of Regional Animal Disease Diagnostics Centre, Udaipur, Rajasthan for providing the cattle sera used in the present study.

Conflict of interest

All the authors have no conflict of interest to declare.


  1. Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godefroid J, Walravens K, Letesson J–J (2001) Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant. Infect Immun 69:4816–4822CrossRefGoogle Scholar
  2. Araya LN, Winter AJ (1990) Comparative protection of mice against virulent and attenuated strains of Brucella abortus by passive transfer of immune T cells or serum. Infect Immun 58:254–256Google Scholar
  3. Cassataro J, Velikovsky CA, Giambartolomei GH, Estein S, Bruno L, Cloeckaert A, Bowden RA, Spitz M, Fossati CA (2000) Immunogenicity of the Brucella melitensis recombinant ribosome recycling factor-homologous protein and its cDNA. Vaccine 20:1660–1669CrossRefGoogle Scholar
  4. Cassataro J, Estein SM, Pasquevich KA, Velikovsky CA, de la Barrera S, Bowden R, Fossati CA, Giambartolomei GH (2005) Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection. Infect Immun 73:8079–8088CrossRefGoogle Scholar
  5. Cassataro J, Pasquevich KA, Estein SM, Laplagne DA, Velikovsky CA, de la Barrera S, Bowden R, Fossati CA, Giambartolomei GH, Goldbaum FA (2007) A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination. Vaccine 25:4437–4446CrossRefGoogle Scholar
  6. Cespedes S, Andrews E, Folch H, Onate A (2000) Identification and partial characterization of a new protective antigen of Brucella abortus. J Med Microbiol 49:165–170Google Scholar
  7. Commander NJ, Spencer SA, Wren BW, MacMillan AP (2007) The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding Brucella melitensis 16 M genes. Vaccine 25:43–54CrossRefGoogle Scholar
  8. Connolly JP, Comerci D, Alefantis TG, Walz A, Quan M, Chafin R, Mujer CV, Ugalde RA, DelVecchio VG (2006) Proteomic analysis of Brucella abortus cell envelope and identification of immunogenic candidate proteins for vaccine development. Proteomics 6:3767–3780CrossRefGoogle Scholar
  9. Jaques I, Cloeckaert A, Linet JN, Dubray G (1992) Protection conferred on mice by combinations of monoclonal antibodies directed against outer-membrane proteins or smooth lipopolysaccharide of Brucella. J Med Microbiol 37:100–103CrossRefGoogle Scholar
  10. Kumar S, Balakrishna K, Agarwal GS, Merwyn S, Rai GP, Batra HV, Sardesai AA, Gowrishankar J (2009) Th-1 type immune response to infection by pYV cured phoP-pohQ null mutant of Yersinia pseudotuberculosis is defective in mouse model. Antonie Van Leeuwenhoek 95:91–100CrossRefGoogle Scholar
  11. Liljeqvist S, Stahl S (1999) Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines. J Biotechnol 73:1–33CrossRefGoogle Scholar
  12. Litwin CM, Johnson JM, Martins TB (2004) The Bartonella henselae sucB gene encodes a dihydrolipoamide succinyltransferase protein reactive with sera from patients with cat-scratch disease. J Med Microbiol 53:1221–1227Google Scholar
  13. Luo D, Ni B, Li P, Shi W, Zhang S, Han Y, Mao L, He Y, Wu Y, Wang X (2006) Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice. Infect Immun 74:2734–2741CrossRefGoogle Scholar
  14. Mariappan V, Vellasam KM, Thimma JS, Hashim OH, Vadivelu J (2010) Identification of immunogenic proteins from Burkholderia cepacia secretome using proteomic analysis. Vaccine 28:1318–1324CrossRefGoogle Scholar
  15. Moriyon I, Grillo MJ, Monreal D, Gonzalez D, Marin C, Lopez-Goni I, Mainar-Jaime RC, Moreno E, Blasco JM (2004) Rough vaccines in animal brucellosis: structural and genetic basis and present status. Vet Res 35:1–38CrossRefGoogle Scholar
  16. Nguyen SV, To H, Yamaguchi T, Fukushi H, Hirai K (1999) Characterization of the Coxiella burnetii sucB gene encoding an immunogenic dihydrolipoamide succinyltransferase. Microbiol Immunol 43:743–749Google Scholar
  17. Oliveira SC, Splitter GA (1996) Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine 14:959–962CrossRefGoogle Scholar
  18. Renukaradhya GJ, Isloor S, Rajasekhar M (2002) Epidemiology, zoonotic aspects, vaccination and control/eradication of brucellosis in India. Vet Microbiol 90:183–195CrossRefGoogle Scholar
  19. Roitt J, Brostoff J, Male D (2001) Immunology. Mosby Publications, LondonGoogle Scholar
  20. Singh M, O’Hagan D (1999) Advances in vaccine adjuvants. Nat Biotechnol 17:1075–1081CrossRefGoogle Scholar
  21. Tabatabai LB, Pugh GW Jr (1994) Modulation of immune responses in BALB/c mice vaccinated with Brucella abortus Cu–Zn superoxide dismutase synthetic peptide vaccine. Vaccine 12:919–924CrossRefGoogle Scholar
  22. Teixeira-Gomes AP, Cloeckaert A, Bezard G, Bowden RA, Dubray G, Zygmunt MS (1997) Identification and characterization of Brucella ovis immunogenic proteins using two dimensional electrophoresis and immunoblotting. Electrophoresis 18:1491–1497CrossRefGoogle Scholar
  23. Velikovsky CA, Goldbaum FA, Cassataro J, Estein S, Bowden RA, Bruno L, Fossati CA, Giambartolomei GH (2003) Brucella lumazine synthase elicits a mixed Th1–Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used. Infect Immun 71:5750–5755CrossRefGoogle Scholar
  24. Vemulapalli R, Cravero S, Calvert CL, Toth TE, Sriranganathan N, Boyle SM, Rossetti OL, Schurig GG (2000) Characterization of specific immune responses of mice inoculated with recombinant vaccinia virus expressing an 18-kDa outer membrane protein of Brucella abortus. Clin Diagn Lab Immunol 7:114–118Google Scholar
  25. Yang X, Hudson M, Walters N, Bargatze RF, Pascual DW (2005) Selection of protective epitopes for Brucella melitensis by DNA vaccination. Infect Immun 73:7297–7303CrossRefGoogle Scholar
  26. Zygmunt MS, Di’az MA, Teixeira-Gomes AP, Cloeckaert A (2001) Cloning, nucleotide sequence, and expression of the Brucella melitensis sucB gene coding for an immunogenic dihydrolipoamide succinyltransferase homologous protein. Infect Immun 69:6537–6540Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  • Shailendra Kumar Verma
    • 1
  • Shikha Jain
    • 1
  • Subodh Kumar
    • 1
  1. 1.Division of MicrobiologyDefense Research and Development EstablishmentGwaliorIndia

Personalised recommendations